Wall Street's major averages rebounded strongly on Friday, a day after stocks closed in correction territory as President ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Wall Street's major averages trade mixed on Wednesday as retail inflation slowed more than expected in February along with ...

TVB-3567 is the Company’s second fatty acid synthase (FASN) inhibitor First-in-human Phase 1 trial initiation planned in 2025 ...

A quarter century later, the Nasdaq is once again in the midst of a new technical revolution with the emergence of AI. Click ...

Jan. 28, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical ... with autoimmune diseases. Today, with the FDA’s clearance of our IND, that vision has become a ...

NLS Pharmaceutics Ltd. (Nasdaq: NLSP”) (“NLS”) and ... based regenerative medicine company, announced today the result from the Type B pre-IND meeting held by Kadimastem and iTolerance ...

Stock index futures climbed on Wednesday as Commerce Secretary Howard Lutnick stoked hopes for a tariff-relief deal. Tariffs are triggering volatility. Don’t wait for tomorrow’s headlines—get the ...

Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that portfolio company PharmNovo received positive feedback regarding its most advanced drug candidate, PN6047, in a pre-IND meeting ...